SCHEMBL6239351

SCHEMBL6239351

CCCC(C(=O)O)C(O)CC#N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 1/20 0.40
AKR1A1 P14550 1/20 0.40
CHRM3 P20309 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
ADRA1A P35348 1/20 0.40
HRH1 P35367 1/20 0.40
DRD3 P35462 1/20 0.40
SLC6A3 Q01959 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
GPR84 Q9NQS5 3/20 0.34
FFAR1 O14842 1/20 0.34
CTSS P25774 1/20 0.33
CTSK P43235 1/20 0.33
GRIK1 P39086 2/20 0.32
GRIK2 Q13002 2/20 0.32
SLC1A2 P43004 2/20 0.32
SLC1A3 P43003 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6240565 0.89 CA2 (0.41) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL395419 0.84 TDP1 (0.33) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL197703 0.84 TDP1 (0.33) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL392365 0.84 TDP1 (0.33) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL198107 0.84 TDP1 (0.33) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL676549 0.79 TDP1 (0.50) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL9636422 0.77 TDP1 (0.48) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL13986496 0.77 TDP1 (0.48) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL1000793 0.77 TDP1 (0.48) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL4286161 0.76 CA2 (0.37) GPR84FFAR1CTSSCTSKGRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005005375-A1 METHOD FOR PRODUCING 4-CYANO-3-HYDROXYBUTYRIC ACID ESTERS LANXESS DEUTSCHLAND GMBH (DE) 2005-01-20 WO disclosed